Ipsen SA
PAR:IPN

Watchlist Manager
Ipsen SA Logo
Ipsen SA
PAR:IPN
Watchlist
Price: 111.3 EUR 2.02% Market Closed
Market Cap: 9.2B EUR
Have any thoughts about
Ipsen SA?
Write Note

Ipsen SA
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Ipsen SA
Cost of Revenue Peer Comparison

Comparables:
SAN
VETO
VIRP
BOI
MEDCL

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Ipsen SA
PAR:IPN
Cost of Revenue
-€618m
CAGR 3-Years
-11%
CAGR 5-Years
-5%
CAGR 10-Years
-7%
Sanofi SA
PAR:SAN
Cost of Revenue
-€18.8B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vetoquinol SA
PAR:VETO
Cost of Revenue
-€275.1m
CAGR 3-Years
-6%
CAGR 5-Years
-7%
CAGR 10-Years
-5%
Virbac SA
PAR:VIRP
Cost of Revenue
-€450.3m
CAGR 3-Years
4%
CAGR 5-Years
1%
CAGR 10-Years
-2%
Boiron SA
PAR:BOI
Cost of Revenue
-€130.8m
CAGR 3-Years
-5%
CAGR 5-Years
0%
CAGR 10-Years
0%
Medincell SA
PAR:MEDCL
Cost of Revenue
-€2.3m
CAGR 3-Years
-16%
CAGR 5-Years
-18%
CAGR 10-Years
N/A

See Also

What is Ipsen SA's Cost of Revenue?
Cost of Revenue
-618m EUR

Based on the financial report for Jun 30, 2024, Ipsen SA's Cost of Revenue amounts to -618m EUR.

What is Ipsen SA's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-7%

Over the last year, the Cost of Revenue growth was -11%. The average annual Cost of Revenue growth rates for Ipsen SA have been -11% over the past three years , -5% over the past five years , and -7% over the past ten years .

Back to Top